Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: Observational Analysis of Adaptions to the Intervention
批准号:
10652751
负责人:
Joseph Edwin Glass
金额:
$38.7万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2025-02-28
关键词:
AbstinenceAddressAdministrative SupplementAdministratorAdoptedAdoptionAgreementAuthorization documentationAwardBehavioralBuprenorphineCOVID-19 impactCaringCellular PhoneClinicCognitiveCognitive TherapyContractsDataDedicationsDoseEducationEffectivenessEnsureEpidemicFaceFundingHealth systemHealthcareHumanInterventionKnowledgeLearningLiteratureMeasuresMedicalMental HealthMethodsModelingOpioidOutcomeParentsPatientsPearPersonsPopulationPrimary CarePrivacyRandomizedRandomized, Controlled TrialsResearch PersonnelRiskRunningSubstance Use DisorderSystemTechnologyTherapeuticTimeTractionTrainingVendorVisitWashingtonWorkWorld Healthauthoritybuprenorphine treatmentcare systemscompare effectivenesscomputerizedcoronavirus diseasecost effectivenessdesigndigitaldigital healthdigital treatmenteffectiveness/implementation hybridevidence basefollow-upformative assessmenthealth planimplementation barriersimplementation scienceimplementation strategyimplementation trialimprovedmodel designnovelnovel strategiesoperationopioid mortalityopioid use disorderpopulation basedpost-COVID-19primary care clinicprimary care patientprimary care teamprovider adoptionpsychosocialrandomized trialscreeningsmartphone applicationsubstance usesuccessvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
The proposed study addresses a critical knowledge gap: How to best implement digital treatments for
opioids and other substance use disorders (SUDs) in primary care (PC). reSET and reSET-O are
smartphone-based, FDA-cleared versions of the Therapeutic Educational System, which is a computerized
cognitive-behavioral treatment for SUDs. We will study their implementation into PC to potentially improve care
for people with SUDs, and as a model for how to sustainably implement digital treatments into real-world
healthcare. Digital treatments could extend the reach of SUD therapy to more people and could address a
significant barrier to buprenorphine prescribing in PC: the lack of access to psychosocial treatment. Delivery
system leaders in Kaiser Permanente Washington are our collaborators for studying strategies for
implementing reSET and reSET-O in Washington State to address prior implementation challenges
documented in the literature. After piloting in 2 clinics, we will randomize up to 23 PC clinics in a 2x2 factorial
design to four approaches: (1) “standard implementation,” which is an evidence-based implementation strategy
previously used by our delivery system partners; (2) “standard implementation with external facilitation,” a
clinician-facing implementation strategy; (3) “standard implementation with patient coach,” a patient-facing
implementation strategy using medical assistants to support patient adoption and engagement; and (4)
“standard implementation with both.” These implementation strategies have some evidence in PC, but their
impact on real-world implementation of a digital treatment has not been evaluated. Specific Aims are to (1)
Estimate the effect of clinician-facing (external facilitation) and patient-facing (patient coach) implementation
strategies in increasing the reach and fidelity of a digital SUD treatment in PC clinics, and (2) compare the
population-level cost-effectiveness of each implementation strategy in increasing reach, fidelity, and
abstinence by patients. This administrative supplement will allow our study to recover from COVID-related
delays and (3) estimate the impact of: training non-social work clinicians to prescribe reSET and reSET-O,
allowing prescriptions without requiring follow-up visits, and centralizing the administrative tasks of prescribing.
IMPACT: Researchers and health systems do not know how to reach large numbers of patients with OUDs
and other SUDs. Digital treatments are promising, but health systems lack evidence to guide implementation of
digital therapies. This study will estimate and compare the effectiveness of clinician-facing and patient-facing
implementation strategies, providing health system leaders with data on how to best implement digital
treatments.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
-
批准号:10493961
-
项目类别:
-
资助金额:$57.05万
-
财政年份:2022
-
负责人:Joseph Edwin Glass
-
依托单位:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
-
批准号:10590820
-
项目类别:
-
资助金额:$20.6万
-
财政年份:2022
-
负责人:Joseph Edwin Glass
-
依托单位:
Multi-level Influences of Alcohol Based Quality and Outcome Measures
-
批准号:10704144
-
项目类别:
-
资助金额:$23.15万
-
财政年份:2022
-
负责人:Joseph Edwin Glass
-
依托单位:
C-DIAS RP3: Scaling-out app-based treatments: a multi-level strategy to promote equity across primary care patients with substance use
-
批准号:10668496
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2022
-
负责人:Joseph Edwin Glass
-
依托单位:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
-
批准号:10092143
-
项目类别:
-
资助金额:$69.0万
-
财政年份:2019
-
负责人:Joseph Edwin Glass
-
依托单位:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
-
批准号:10349443
-
项目类别:
-
资助金额:$66.32万
-
财政年份:2019
-
负责人:Joseph Edwin Glass
-
依托单位:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
-
批准号:9902391
-
项目类别:
-
资助金额:$74.33万
-
财政年份:2019
-
负责人:Joseph Edwin Glass
-
依托单位:
Digital treatments for opioids and other substance use disorders (DIGITS) in primary care: A hybrid type-III implementation trial
-
批准号:10560538
-
项目类别:
-
资助金额:$59.63万
-
财政年份:2019
-
负责人:Joseph Edwin Glass
-
依托单位:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
-
批准号:9981556
-
项目类别:
-
资助金额:$18.18万
-
财政年份:2017
-
负责人:Joseph Edwin Glass
-
依托单位:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
-
批准号:10222485
-
项目类别:
-
资助金额:$18.1万
-
财政年份:2017
-
负责人:Joseph Edwin Glass
-
依托单位:
Decreasing the Engagement Gap for Addiction Treatment in Primary Care
-
批准号:9754566
-
项目类别:
-
资助金额:$18.64万
-
财政年份:2017
-
负责人:Joseph Edwin Glass
-
依托单位:
Racial/ethnic Disparities in Alcohol Outcomes and Health Service
-
批准号:9340854
-
项目类别:
-
资助金额:$8.0万
-
财政年份:2016
-
负责人:Joseph Edwin Glass
-
依托单位:
Racial/ethnic Disparities in Alcohol Outcomes and Health Service
-
批准号:8893302
-
项目类别:
-
资助金额:$7.44万
-
财政年份:2015
-
负责人:Joseph Edwin Glass
-
依托单位:
Perceived alcohol stigma and treatment for alcohol use disorders
-
批准号:8254193
-
项目类别:
-
资助金额:$2.98万
-
财政年份:2011
-
负责人:Joseph Edwin Glass
-
依托单位:
海外基金